Bromodomain PHD‑finger Transcription Factor Promotes Glioma Progression and Indicates Poor Prognosis

Overview

Journal Oncol Rep

Specialty Oncology

Date 2018 Dec 14

PMID 30542695

Citations 12

Authors

Yanling Pan

Feng Yuan

Yijie Li

Guoping Wang

Zhiren Lin

Longhua Chen

Affiliations

Soon will be listed here.

Abstract

Glioma is one of the most deadly central nervous system tumors around the world. Uncontrollable cell proliferation and invasion are key factors of cancer progression as well as glioma. Available evidence suggests that bromodomain PHD‑finger transcription factor (BPTF) plays an important role in stem cell proliferation and differentiation, as well as in progression of some tumors, but there is little data on glioma. Therefore, the present study aimed to explore the functional role and potential clinical value of BPTF in glioma. Public database, real‑time PCR and western blotting were used to detect the expression of BPTF in glioma tissue and cells. The relationship between BPTF with clinicopathological features and the prognosis of glioma patients was analyzed by immunohistochemical staining in 113 cases of paraffin‑embedded primary glioma specimens. Furthermore, cytological experiments were conducted to elucidate the functional role of BPTF in glioma U251 cells, as well as the potential molecular mechanism. The expression of BPTF in glioma tissues was significantly higher than that in normal brain tissues. The association analysis results revealed that high BPTF expression was significantly associated with WHO grade and tumor size. Survival analysis revealed that the BPTF high‑expression group had poorer overall survival (OS) and progression‑free survival (PFS) compared with the low‑expression group. Univariate and multivariate Cox regression analyses revealed that BPTF expression was an independent prognostic factor for the OS and PFS of glioma patients. Cytological experiments revealed that BPTF overexpression could significantly promote the proliferation, migration and invasion of human glioma U251 cells. A study of the underlying mechanism indicated that BPTF promoted glioma progression via MYC signaling. Our results preliminarily indicated that BPTF promoted glioma progression via MYC signaling and may be a potential prognostic biomarker and therapeutic target for glioma patients.

Citing Articles

Chromatin remodeling protein BPTF mediates chromatin accessibility at gene promoters in planarian stem cells.

Verma P, Allen J, Sanchez Alvarado A, Duncan E BMC Genomics. 2025; 26(1):232.

PMID: 40069606 PMC: 11895202. DOI: 10.1186/s12864-025-11405-3.

Lumbrokinase Extracted from Synergizes with Bevacizumab and Chemotherapeutics in Treating Non-Small Cell Lung Cancer by Targeted Inactivation of BPTF/VEGF and NF-κB/COX-2 Signaling.

Hua C, Guo Z, Dai M, Zhou J, Ge H, Xue G Biomolecules. 2024; 14(7).

PMID: 39062456 PMC: 11274885. DOI: 10.3390/biom14070741.

BPTF promotes glioma development through USP34-mediated de-ubiquitination of FOXC1.

Pan Y, Yuan F, Lin Z, Li Y Histol Histopathol. 2024; 40(2):205-214.

PMID: 38686761 DOI: 10.14670/HH-18-748.

BPTF Drives Gastric Cancer Resistance to EGFR Inhibitor by Epigenetically Regulating the C-MYC/PLCG1/Perk Axis.

Li F, Yu J, Pan T, Feng H, Li J, Yu B Adv Sci (Weinh). 2023; 10(34):e2303091.

PMID: 37863665 PMC: 10700682. DOI: 10.1002/advs.202303091.

Bromodomain (BrD) Family Members as Regulators of Cancer Stemness-A Comprehensive Review.

Czerwinska P, Mackiewicz A Int J Mol Sci. 2023; 24(2).

PMID: 36674511 PMC: 9861003. DOI: 10.3390/ijms24020995.

References

Minniti G, Muni R, Lanzetta G, Marchetti P, Enrici R . Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer Res. 2010; 29(12):5171-84. View

Boruah D, Deb P, Srinivas V, Mani N . Morphometric study of nuclei and microvessels in gliomas and its correlation with grades. Microvasc Res. 2014; 93:52-61. DOI: 10.1016/j.mvr.2014.03.002. View

Xiao S, Liu L, Fang M, Zhou X, Peng X, Long J . BPTF Associated with EMT Indicates Negative Prognosis in Patients with Hepatocellular Carcinoma. Dig Dis Sci. 2014; 60(4):910-8. DOI: 10.1007/s10620-014-3411-0. View

Principe D, Doll J, Bauer J, Jung B, Munshi H, Bartholin L . TGF-β: duality of function between tumor prevention and carcinogenesis. J Natl Cancer Inst. 2014; 106(2):djt369. PMC: 3952197. DOI: 10.1093/jnci/djt369. View

Stine Z, Walton Z, Altman B, Hsieh A, Dang C . MYC, Metabolism, and Cancer. Cancer Discov. 2015; 5(10):1024-39. PMC: 4592441. DOI: 10.1158/2159-8290.CD-15-0507. View

Ma Y, Liu X, Liu Z, Wei S, Shang H, Xue Y . The Chromatin Remodeling Protein Bptf Promotes Posterior Neuroectodermal Fate by Enhancing Smad2-Activated wnt8a Expression. J Neurosci. 2015; 35(22):8493-506. PMC: 6605332. DOI: 10.1523/JNEUROSCI.0377-15.2015. View

Xu B, Cai L, Butler J, Chen D, Lu X, Allison D . The Chromatin Remodeler BPTF Activates a Stemness Gene-Expression Program Essential for the Maintenance of Adult Hematopoietic Stem Cells. Stem Cell Reports. 2018; 10(3):675-683. PMC: 5918338. DOI: 10.1016/j.stemcr.2018.01.020. View

Landry J, Sharov A, Piao Y, Sharova L, Xiao H, Southon E . Essential role of chromatin remodeling protein Bptf in early mouse embryos and embryonic stem cells. PLoS Genet. 2008; 4(10):e1000241. PMC: 2570622. DOI: 10.1371/journal.pgen.1000241. View

Goller T, Vauti F, Ramasamy S, Arnold H . Transcriptional regulator BPTF/FAC1 is essential for trophoblast differentiation during early mouse development. Mol Cell Biol. 2008; 28(22):6819-27. PMC: 2573307. DOI: 10.1128/MCB.01058-08. View

10.

Richart L, Real F, Sanchez-Arevalo Lobo V . c-MYC partners with BPTF in human cancer. Mol Cell Oncol. 2016; 3(3):e1152346. PMC: 4909403. DOI: 10.1080/23723556.2016.1152346. View

11.

Xiao S, Liu L, Lu X, Long J, Zhou X, Fang M . The prognostic significance of bromodomain PHD-finger transcription factor in colorectal carcinoma and association with vimentin and E-cadherin. J Cancer Res Clin Oncol. 2015; 141(8):1465-74. DOI: 10.1007/s00432-015-1937-y. View

12.

Hanahan D, Weinberg R . Hallmarks of cancer: the next generation. Cell. 2011; 144(5):646-74. DOI: 10.1016/j.cell.2011.02.013. View

13.

Dar A, Majid S, Bezrookove V, Phan B, Ursu S, Nosrati M . BPTF transduces MITF-driven prosurvival signals in melanoma cells. Proc Natl Acad Sci U S A. 2016; 113(22):6254-8. PMC: 4896689. DOI: 10.1073/pnas.1606027113. View

14.

Jordan-Sciutto K, Dragich J, Caltagarone J, Hall D, Bowser R . Fetal Alz-50 clone 1 (FAC1) protein interacts with the Myc-associated zinc finger protein (ZF87/MAZ) and alters its transcriptional activity. Biochemistry. 2000; 39(12):3206-15. PMC: 3667205. DOI: 10.1021/bi992211q. View

15.

Mayes K, Elsayed Z, Alhazmi A, Waters M, Alkhatib S, Roberts M . BPTF inhibits NK cell activity and the abundance of natural cytotoxicity receptor co-ligands. Oncotarget. 2017; 8(38):64344-64357. PMC: 5610007. DOI: 10.18632/oncotarget.17834. View

16.

Buganim Y, Goldstein I, Lipson D, Milyavsky M, Polak-Charcon S, Mardoukh C . A novel translocation breakpoint within the BPTF gene is associated with a pre-malignant phenotype. PLoS One. 2010; 5(3):e9657. PMC: 2836376. DOI: 10.1371/journal.pone.0009657. View

17.

Jones M, Hamana N, SHIMANE M . Identification and characterization of BPTF, a novel bromodomain transcription factor. Genomics. 2000; 63(1):35-9. DOI: 10.1006/geno.1999.6070. View

18.

Ho V, Reijneveld J, Enting R, Bienfait H, Robe P, Baumert B . Changing incidence and improved survival of gliomas. Eur J Cancer. 2014; 50(13):2309-18. DOI: 10.1016/j.ejca.2014.05.019. View

19.

Livak K, Schmittgen T . Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2002; 25(4):402-8. DOI: 10.1006/meth.2001.1262. View

20.

Richart L, Pau E, Rio-Machin A, de Andres M, Cigudosa J, Sanchez-Arevalo Lobo V . BPTF is required for c-MYC transcriptional activity and in vivo tumorigenesis. Nat Commun. 2016; 7:10153. PMC: 4728380. DOI: 10.1038/ncomms10153. View